Types of Pancreatic Cancer 

Pancreatic cancer begins when abnormal cells within the pancreas grow out of control and form a tumor. There are two types of cells in the pancreas, the exocrine cells and endocrine cells. These cells also have different functions.

More than 95% of pancreatic cancers are classified as exocrine tumors. These tumors start in the exocrine cells that make pancreatic enzymes that help in digestion. Within this category, the vast majority of tumors are adenocarcinomas. The following table describes the different types of pancreatic exocrine tumors. Click here to learn about types of exocrine tumors in the pancreas.

Pancreatic neuroendocrine tumors (pancreatic NETs or PNETs) account for less than 5% of all pancreatic tumors.  They may be benign or malignant and they tend to grow slower than exocrine tumors.  They develop from the abnormal growth of endocrine (hormone-producing) cells in the pancreas called islet cells.  This is why these tumors are sometimes referred to as “islet cell tumors.”

Pancreatic neuroendocrine tumors are either functional (produce hormones) or nonfunctional (produce no hormones). The majority of PNETs are nonfunctional tumors.  Click here to learn about types of endocrine tumors in the pancreas.

The information and services provided by the Pancreatic Cancer Action Network, Inc. are for informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnosis or treatment. If you are ill, or suspect that you are ill, see a doctor immediately! The Pancreatic Cancer Action Network does not recommend nor endorse any specific physicians, products or treatments even though they may be mentioned on this site. In addition, please note that any personal information you provide to the Pancreatic Cancer Action Network’s associates during telephone and/or email consultations may be stored in a secure database to assist the Pancreatic Cancer Action Network, Inc. in providing you with the best service possible. Portions of the constituent data stored in this database may be used to inform future programs and services of the Pancreatic Cancer Action Network, Inc., and may be provided in aggregate form to third parties to guide future pancreatic cancer research and treatment efforts. The Pancreatic Cancer Action Network, Inc. will not provide personal identifying information (such as your name or contact information) to third parties without your advanced written consent. 131217